Dr. Mekdes Megeressa, Ph.D. Research Associate
Ph.D. Pharmaceutical Sciences, Chapman University, Irvine, California, USA
Dr. Seema Saroj, Ph.D.
Ph.D. Pharmaceutics, The Maharaja Sayajirao University, India
External Position: Research Associate, Alembic Pharmaceuticals, India
Neha S. Tomar, Ph.D. (In progress)
Ph.D. (ongoing) Neuroscience, University of Salford, UK
Ara V. Abbott, MS
MS Individualized Genomics and Health, Johns Hopkins University, Baltimore, MD, USA
Heba Fleihan, MS
MS Biochemistry and Molecular Genetics, American University of Beirut, Lebanon
Genomics, especially high-performance sequencing and characterization of expressed human genes, has provided new possibilities for drug discovery. We perform literature reviews and data analysis in the areas of genomics, proteomics, bioinformatics, drug-protein, drug-membrane binding, and different drug delivery systems
Our Genomics and Drug Development group carries out researches in the following areas:
Endometrial cancer (EC) is the most commonly diagnosed cancer of the female reproductive system. Similar to other forms of cancer, early detection, and accurate intervention is of vital importance. This research aims to identify potential biomarkers and significant alterations in gene expression by conducting RNA-seq analysis of publicly available cancer datasets. Additionally, successful pregnancy has been identified by multiple studies as a preventative factor for EC. Our research also aims to explore the mechanisms during a successful pregnancy that can potentially mitigate EC risks.